Terms ending in 2035
Every in-force patent on Cardea Bio, Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,921,112 | Chemically-Sensitive Field Effect Transistors, Systems, and Methods for Manufacturing and Using the Same In force · Medium confidence | Paragraf USA Inc. | In force | Medium confidence | |
| US 11,536,722 | Chemically-Sensitive Field Effect Transistors, Systems, and Methods for Manufacturing and Using the Same In force · Medium confidence | Nanomedical Diagnostics, Inc. | In force | Medium confidence | |
| US 12,298,301 | Chemically-Sensitive Field Effect Transistors, Systems, and Methods for Manufacturing and Using the Same In force · Medium confidence | Nanomedical Diagnostics, Inc. | In force | Medium confidence | |
| US 11,782,057 | Ic with Graphene Fet Sensor Array Patterned in Layers Above Circuitry Formed in a Silicon Based CMOS Wafer In force · Medium confidence | Cardea Bio, Inc. | In force | Medium confidence | |
| US 9,618,474 | Graphene Fet Devices, Systems, and Methods of Using the Same for Sequencing Nucleic Acids In force · High confidence | Cardea Bio, Inc. | In force | High confidence | |
| US 9,857,328 | Chemically-Sensitive Field Effect Transistors, Systems, and Methods for Manufacturing and Using the Same In force · High confidence | Cardea Bio, Inc. | In force | High confidence | |
| US 9,859,394 | Graphene Fet Devices, Systems, and Methods of Using the Same for Sequencing Nucleic Acids In force · Medium confidence | Cardea Bio, Inc. | In force | Medium confidence | |
| US 10,006,910 | Chemically-Sensitive Field Effect Transistors, Systems, and Methods for Manufacturing and Using the Same In force · High confidence | Cardea Bio, Inc. | In force | High confidence | |
| US 10,020,300 | Graphene Fet Devices, Systems, and Methods of Using the Same for Sequencing Nucleic Acids In force · Medium confidence | Cardea Bio, Inc. | In force | Medium confidence | |
| US 10,429,342 | Chemically-Sensitive Field Effect Transistor In force · High confidence | Cardea Bio, Inc. | In force | High confidence | |
| 6 more term ends in 2035 · Pro | |||||
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
12 of these are in force and held by Cardea Bio, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.